|
|
Cadista Pharmaceuticals, Inc. is the global generics business unit of Jubilant Organosys Limited , an Indian multinational company with specialization in pharmaceutical research and development, manufacturing and industry support services. The company currently serves the U.S. and European markets, with production from an FDA-approved facility in Salisbury, MD and a newly-commissioned plant in Roorkee, India.
Cadista utilizes vertical integration — from base chemicals to final distribution. Increasingly, it focuses on relevant extended and immediate release oral solid products to deliver high value to the global marketplace. The company has maintained a strong presence in the growing generics market. Cadista currently has a portfolio of more than 70 products in various stages of development. The company markets 10 ANDAs, and expects to launch many more over the next five to seven years in the U.S. |
|
|
|Privacy Policy |
Terms & Conditions |